BCL6B and hepatocellular carcinoma: In paired primary cancer and adjacent non-cancer tissues from 126 HCC patients (quantitative PCR cohort), 92 cases (73.0%) exhibited significant downregulation of BCL6B in cancer tissues (Figure 1A).